Dietary Isosaponarin is Intestinally Metabolized to Isovitexin, Most of Which are Excreted in Feces without Being Absorbed
Published: 28-03-2023
Page: 104-116
Issue: 2023 - Volume 2 [Issue 3]
Takashi Hashimoto *
Division of Applied Chemistry in Bioscience, Graduate School of Agricultural Science, Kobe University, Rokkodai-cho 1-1, Nada-ku, Kobe 657-8501, Japan.
Jiansheng Long
Division of Applied Chemistry in Bioscience, Graduate School of Agricultural Science, Kobe University, Rokkodai-cho 1-1, Nada-ku, Kobe 657-8501, Japan.
Kazuki Kanazawa
Division of Applied Chemistry in Bioscience, Graduate School of Agricultural Science, Kobe University, Rokkodai-cho 1-1, Nada-ku, Kobe 657-8501, Japan.
*Author to whom correspondence should be addressed.
Abstract
Objective: The metabolism of isosaponarin was investigated using a Caco-2 intestinal epithelial model and animal experiment.
Background: Isosaponarin is a flavonoid in wasabi (Wasabia japonica) leaves and has unique structure, in which two glucose molecules bind to apigenin through O-glycosidic and C-glycosidic bonds.
Materials and Methods: The absorption and metabolism of isosaponarin was investigated by a Caco-2 intestinal epithelial model in vitro and a single oral administration to mice in vivo.
Results: These experiments showed that isosaponarin was hardly absorbed into the body. However, isosaponarin was metabolized to isovitexin (apigenin-6-C-glucoside) by hydrolysis of O-glycosidic bond. This hydrolysis was mainly caused at small intestine, and the gastric acid in the stomach might partially contribute to the hydrolysis. Both Caco-2 intestinal epithelial model and animal experiment indicated that isovitexin was also not absorbed into the body, and that half of the administered isosaponarin was excreted as isovitexin in feces.
Conclusion: Half of the administered isosaponarin was metabolized to isovitexin in the intestinal tract and then excreted, and the rest was probably degraded by intestinal microflora. Therefore, it was suggested that the bioavailability of dietary isosaponarin is very low.
Keywords: Isosaponarin, isovitexin, wasabi, Wasabia japonica, Caco-2 cells, ICR mice
How to Cite
Downloads
References
Chadwick CI, Lumpkin TA, Elberson LR. The botany, uses and production of Wasabia japonica (Miq.) (Cruciferae) Matsum Econ. Bot. 1993;47(2):113-35.
Hashimoto T, Yamada T, Nagai M, Yamada K, Tanaka M, Shimoaki T, et al. Wasabi. In: Govil JN,Singh VK, editors. Recent progress in medicinal plants ethonomedicune: Source & Mechanism, Studium Press LLC (USA). 2010;30:65-84.
Kinae N, Masuda H, Shin IS, Furugori M, Shimoi K. Functional properties of wasabi and horseradish. BioFactors. 2000;13:265-9.
Uto T, Fujii M, Hou D-X. 6-(Methylsulfinyl) hexyl isothiocyanate suppresses inducible nitric oxide synthase expression through the inhibition of Janus kinase 2-mediated JNK pathway in lipopolysaccharide-activated murine macrophages. Biochem Pharmacal. 2005;70:1211-21.
Morimitsu Y, Nakagawa Y, Hayashi K, Fujii H, Kumagai T, Nakamura Y, et al. A sulforaphane analogue that potently activates the Nrf2-dependent detoxification pathway. J Biol Chem. 2002;5:3456-63.
Nagai M, Akita K, Yamada K, Okunishi I. The effect of isosaponarin isolated from wasabi leaf on collagen synthesis in human fibroblasts and its underlying mechanism. J Nat Med. 2010;64(3):305-12.
Lu CW, Yeh KC, Chiu KM, Lee MY, Lin TY, Wang SJ. The effect of isosaponarin derived from wasabi leaves on glutamate release in rat synaptosomes and its underlying mechanism. Int J Mol Sci. 2022;23(15):8752.
Spencer JP, Chowrimootoo G, Choudhury R, Debnam ES, Srai SK, Rice-Evans C. The small intestine can both absorb and glucuronidate luminal flavonoids. FEBS Lett. 1999;458(2):224-30.
Walgren RA, Lin J-T, Kinne RK-H, Walle T. Cellular uptake of dietary flavonoid quercetin 4'-β-glucoside by sodium-dependent glucose transporter SGLT1. J Pharmacol Exp Ther. 2000; 294(3):837-43.
Ioku K, Pongpiriyadacha Y, Konishi Y, Takei Y, Nakatani N, Terao J. β-Glucosidase activity in the rat small intestine toward quercetin monoglucosides. Biosci Biotechnol Biochem. 1998;62:1428-31.
Day AJ, Canada JF, Diaz JC, Kroon PA, Mclauchlan R, Faulds CB, et al. Dietary flavonoid and isoflavone glycosides are hydrolysed by the lactase site of lactase phlorizin hydrolase. FEBS Lett. 2000;468(2-3):166-70.
Rice-Evans C. Flavonoids and isoflavones: absorption, metabolism, and bioactivity. Free Radic Biol Med. 2004; 36,827-8.
Walle T. Absorption and metabolism of flavonoids. Free Radic Biol Med. 2004;36:829-37.
Graefe EU, Wittig J, Mueller S, Riethling AK, Uehleke B, Drewelow B, et al. Pharmacokinetics and bioavailability of quercetin glycosides in humans. J Clin Pharmacol. 2001;41:492-9.
Murota K, Shimizu S, Miyamoto S, Izumi T, Obata A, Kikuchi M, et al. Unique uptake and transport of isoflavone aglycones by human intestinal caco-2 cells: comparison of isoflavonoids and flavonoids. J Nutr. 2002;132(7):1956-61.
Abou-Zaid MM, Lombardo DA, Kite GC, Grayer RJ, Veitch NC. Acylated flavone C-glycosides from Cucumis sativus. Phytochemistry. 2001;58:167-72.
Krafczyk N, Glomb MA. Characterization of phenolic compounds in rooibos tea. J Agric Food Chem. 2008; 56,3368-76.
Joubert E. HPLC quantification of the dihydrochalcones, aspalathin and nothofagin in rooibos tea (Aspalathus linearis) as affected by processing. Food Chem. 1996;55:403-11.
Zhang Y, Tie X, Bao B, Wu X, Zhang Y. Metabolism of flavone C-glucosides and p-coumaric acid from antioxidant of bamboo leaves (AOB) in rats. Br J Nutr. 2007;97:484-94.
Murota K, Shimizu S, Chujo H, Moon J-H, Terao J. Efficiency of absorption and metabolic conversion of quercetin and its glucosides in human intestinal cell line Caco-2. Arch Biochem Biophys. 2000;384(2):391-7.
Walton MC, Hendriks WH, Broomfield AM, McGhie TK. Viscous food matrix influences absorption and excretion but not metabolism of blackcurrant anthocyanins in rats. J Food Sci. 2009;74:22-9.
Prasain JK, Jones K, Brissie N, Moore R, Wyss JM., Barnes S. Identification of puerarin and its metabolites in rats by liquid chromatography-tandem mass spectrometry. J Agric Food Chem. 2004;52(12):3708-12.
Yasuda T, Kano Y, Saito K, Ohsawa K. Urinary and biliary metabolites of puerarin in rats. Biol Pharm Bull. 1995;18:300-3.
Hultin PG. Bioactive C-glycosides from bacterial secondary metabolism. Curr Top Med Chem. 2005;5:1299-331.
Fanz G, Grun M. Chemistry, occurrence and biosynthesis of C-glycosyl compounds in plants. Planta Med. 1983;47:131-40.
Folador P, Cazarolli LH, Gazola AC, Reginatto FH, Schenkel EP, Silva FR. Potential insulin secretagogue effects of isovitexin and swertisin isolated from Wilbrandia ebracteata roots in non-diabetic rats. Fitoterapia. 2010;81:1180-7.
Huang ST, Chen CT, Chieng KT, Huang SH, Chiang BH, Wang LF, et al. Inhibitory effects of a rice hull constituent on tumor necrosis factor α, prostaglandin E2, and cyclooxygenase-2 production in lipopolysaccharide-activated mouse macrophages. Ann N Y Acad Sci. 2005;1042:387-95.
Cao XY, Wang XH, Ma SL, Yang XJ, Wang XQ, Ding H, et al. Study of relationship between stress hyperglycemia and insulin-resistance related factors. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2006;12:751- 4.
Sezik E, Aslan M, Yesilada E, Ito S. Hypoglycaemic activity of Gentiana olivieri and isolation of the active constituent through bioassay- directed fractionation techniques. Life Sci. 2005;76(11):1223- 38.
Kang KA, Zhang R, Chae S, Lee SJ, Kim J, Kim J, et al. Phloroglucinol (1,3,5-trihydroxybenzene) protects against ionizing radiation-induced cell damage through inhibition of oxidative stress in vitro and in vivo. Chem Biol Interact. 2010;185:215-26.
Li TT, Zhang YS, He L, Li NS, Peng J, Li YJ. Protective effect of phloroglucinol against myocardial ischaemia-reperfusion injury is related to inhibition of myeloperoxidase activity and inflammatory cell infiltration. Clin Exp Pharmacol Physiol. 2011;38:27-33.
Huberman L, Gollop N, Mumcuoglu KY, Breuer E, Bhusare SR, Shai Y, et al. Antibacterial substances of low molecular weight isolated from the blowfly, Lucilia sericata. Med Vet Entomol. 2007;21:127-31.